FRIDAY, Nov. 19, 2021 (HealthDay News) — The COVID-19 pandemic, heart-healthy eating, and better ways to treat and prevent heart disease were among the hot topics that emerged during the American Heart Association’s annual meeting this week. “I was at the sessions yesterday, I was actually in clinic this morning,Continue Reading

Cardiologists’ meeting brings new insights, advances. The COVID-19 pandemic, heart-healthy eating, and better ways to treat and prevent heart disease were among the hot topics that emerged during the American Heart Association’s annual meeting this week. Read more Switch to plant-based diet brought relief to man with severe migraine. TheContinue Reading

FRIDAY, Nov. 19, 2021 (HealthDay News) — While climate change gets a lot of notice for its numerous negative impacts around the globe, children’s allergies may not be among them. Despite climate change, with the longer growing seasons and larger pollen loads that are attributed to it, more than 5,800Continue Reading

THURSDAY, Nov. 19, 2021 (HealthDay News) – People who live with chronic migraines suffer intense throbbing and pulsing, sensitivity to light and sound, nausea and vomiting. Could a plant-based diet, credited with a variety of positive health impacts, also help ease these chronic symptoms? It might. Researchers in New YorkContinue Reading

FRIDAY, Nov. 16, 2021 (HealthDay News) — Low-dose aspirin neither reduces nor increases the risk of dementia in adults with type 2 diabetes, a new study finds. “This is reassuring that an increase in the risk of dementia is unlikely for the millions of people worldwide who regularly take aspirinContinue Reading

FRIDAY, Nov. 19, 2021 (HealthDay News) — Guidelines for treating movement problems in people in the early stages of Parkinson’s disease have been updated. The new treatment recommendations from the American Academy of Neurology (AAN) focus on dopaminergic medications, which increase dopamine levels or mimic dopamine effects. Parkinson’s is aContinue Reading

THURSDAY, Nov. 18, 2021 (HealthDay News) — Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines. “Aducanumab is not a cure for Alzheimer’s disease,Continue Reading